Cartiva has won an FDA premarket approval for its cartilage implant to treat osteoarthritis at the base of the big toe. It is the first synthetic cartilage implant approved by the FDA.
The Synthetic Cartilage Implant (SCI) is an alternative to standard of care: fusing the bones in the foot with screws and plates. While this effectively takes care of pain from the arthritic joint, it also permanently stops it from moving.
A biocompatible, biomedical polymer implant designed to mimic the physical characteristics of articular cartilage, the implant replaces damaged cartilage, relieving pain while maintaining joint function. The procedure takes about 35 minutes and, unlike fusion, allows patients to immediately put as much weight as they can tolerate on the foot.